+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Active Pharmaceutical Ingredient (API) Market - Analysis By Drug Type (Generic, Innovative), Synthesis (Synthetic, Biotech), By Application, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)

  • ID: 5518206
  • Report
  • December 2021
  • Region: Global
  • 230 Pages
  • Azoth Analytics

According to the report, the Global Active Pharmaceutical Ingredients Market is projected to display robust growth represented by a CAGR of 6.96% during 2021–2026. The global Active Pharmaceutical Ingredients Market was valued at USD 179.6 Billion in the year 2020. Growth opportunities for the Active Pharmaceutical Ingredient market is attributed to the growth of geriatric population, rising technical advancements, increasing API manufacturing facilities in the world and increasing number of research and development activities by some of the key market players in the global platform.



Growing awareness as well as investments in development of new drugs in the market is pushing the number of clinical trials in the world which is driving up the Active Pharmaceutical Ingredient market. With rising prevalence of respiratory diseases due to the outbreak of COVID-19, it is expected that there will be more demand for new drugs which is likely to push the demand for API and consequently affect the Global Active Pharmaceutical Market in the world.



The biopharma companies are opting for mergers and acquisitions to gain access to new technologies, expand their market area and increase their capital for clinical trials and investments. The API market has been witnessing impressive growth since the past few years. This growth trend is projected to continue due to the increase in demand from Asia Pacific region in the future. This is mainly driven by China, India and Japan which consist of huge population and thereby huge incidence of infectious diseases which require medicines for treatment.



The rising death toll and spread of the virus prompted many pharmaceutical companies, biopharmaceutical companies and small startups to collaborate and bring out effective medicine to fight the same. Scientist all over the world found molecules which can effectively target COVID-19. Currently 155 molecules are under the clinical investigation, and 45 molecules are under preclinical development to be targeted against COVID-19. Companies monitored locally to protect the safety of study participants, staff and employees during such times.



Scope of the Report

  • The report presents the analysis of Active Pharmaceutical Ingredients market for the historical period of 2016-2020 and the forecast period of 2021-2026.
  • The report analyses the Active Pharmaceutical Ingredients Market by value (USD Billion)
  • The report analyses the Active Pharmaceutical Ingredients Market by Application (Oncology, Cardiology, Diabetes, Neurology and Others)
  • The report analyses the Active Pharmaceutical Ingredients Market by Drug Type(Generic API and Innovative API)
  • The report analyses the Active Pharmaceutical Ingredients Market by Synthesis (Synthetic and Biotech)
  • The Global Active Pharmaceutical Ingredients Market has been analysed By Region (North America, Europe, Asia Pacific and LAMEA)
  • The Global Active Pharmaceutical Ingredients Market has been analysed By Country (United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan and India)
  • The attractiveness of the market has been presented by region, by Application, By Drug Type and by Synthesis.
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Pfizer Inc., GlaxoSmithKline, AbbVie Inc., Novartis AG, Eli Lilly and Company, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sanofi, Bristol-Myers Squibb and Boehringer Ingelheim.

Key Target Audience:

  • Active Pharmaceutical Ingredients Manufacturers
  • Consulting and Advisory Firms
  • Government and Policy Makers
  • Regulatory Authorities
Note: Product cover images may vary from those shown

1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations3. Active Pharmaceutical Ingredients Market: Product Outlook
4. Global Active Pharmaceutical Ingredients Market: Size and Forecast
4.1 Global Active Pharmaceutical Ingredient Market Size, By Value, Year 2016-2026
5. Global Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis
5.1 Competitive Scenario of Global Active Pharmaceutical Ingredient Market: By Application
5.1.1 Oncology - Market Size and Forecast (2016-2026)
5.1.2 Cardiology- Market Size and Forecast (2016-2026)
5.1.3 Diabetes - Market Size and Forecast (2016-2026)
5.1.4 Neurology - Market Size and Forecast (2016-2026)
5.1.5 Others - Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Active Pharmaceutical Ingredient Market: By Drug Type
5.2.1 Generic API- Market Size and Forecast (2016-2026)
5.2.2 Innovative API - Market Size and Forecast (2016-2026)
5.3 Competitive Scenario of Global Active Pharmaceutical Ingredient Market: By Synthesis
5.3.1 Synthetic - Market Size and Forecast (2016-2026)
5.3.2 Biotech - Market Size and Forecast (2016-2026)
6. Global Active Pharmaceutical Ingredients Market: Regional Analysis
6.1 Competitive Scenario of Global Active Pharmaceutical Ingredients Market: By Region
7. North America Active Pharmaceutical Ingredient Market: An Analysis (2016-2026)
7.1 North America Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
7.2 North America Active Pharmaceutical Ingredient Market - Prominent Companies
7.3 Market Segmentation By Application (Oncology, Cardiology, Diabetes, Neurology and Others)
7.4 Market Segmentation By Drug Type (Generic API and Innovative API)
7.5 Market Segmentation By Synthesis (Synthetic and Biotech)
7.6 North America Active Pharmaceutical Ingredient Market: Country Analysis
7.7 Market Opportunity Chart of North America Active Pharmaceutical Ingredient Market - By Country, By Value, 2026
7.8 Competitive Scenario of North America Active Pharmaceutical Ingredient Market: By Country
7.9 United States Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
7.10 United States Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
7.11 Canada Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
7.12 Canada Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
8. Europe Active Pharmaceutical Ingredient Market: Segmentation: An Analysis (2016-2026)
8.1 Europe Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
8.2 Europe Active Pharmaceutical Ingredient Market - Prominent Companies
8.3 Market Segmentation By Application (Oncology, Cardiology, Diabetes, Neurology and Others)
8.4 Market Segmentation By Drug Type (Generic API and Innovative API)
8.5 Market Segmentation By Synthesis (Synthetic and Biotech)
8.6 Europe Active Pharmaceutical Ingredient Market: Country Analysis
8.7 Market Opportunity Chart of Europe Active Pharmaceutical Ingredient Market - By Country, By Value, 2026
8.8 Competitive Scenario of Europe Active Pharmaceutical Ingredient Market: By Country
8.9 Germany Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
8.10 Germany Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
8.11 United Kingdom Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
8.12 United Kingdom Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
8.13 France Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
8.14 France Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
8.15 Spain Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
8.16 Spain Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
8.17 Italy Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
8.18 Italy Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
9. Asia Pacific Active Pharmaceutical Ingredient Market: : An Analysis (2016-2026)
9.1 Asia Pacific Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Active Pharmaceutical Ingredient Market - Prominent Companies
9.3 Market Segmentation By Application (Oncology, Cardiology, Diabetes, Neurology and Others)
9.4 Market Segmentation By Drug Type (Generic API and Innovative API)
9.5 Market Segmentation By Synthesis (Synthetic and Biotech)
9.6 Asia Pacific Active Pharmaceutical Ingredient Market: Country Analysis
9.7 Market Opportunity Chart of Asia Pacific Active Pharmaceutical Ingredient Market - By Country, By Value, 2026
9.8 Competitive Scenario of Asia Pacific Active Pharmaceutical Ingredient Market: By Country
9.9 China Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
9.10 China Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
9.11 Japan Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
9.12 Japan Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
9.13 India Active Pharmaceutical Ingredient Market: Size and Forecast (2016-2026), By Value
9.14 India Active Pharmaceutical Ingredient Market Segmentation - By Application, By Drug Type, By Synthesis (2016-2026)
10. Global Active Pharmaceutical Ingredients Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market - By Application, 2026
11.2 Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market - By Drug Type, 2026
11.3 Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market - By Synthesis, 2026
11.4 Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market - By Region, 2026
12. Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Market Share Analysis
13. Company Profiles
13.1 Pfizer Inc.,
13.2 GlaxoSmithKline
13.3 AbbVie Inc.
13.4 Novartis AG
13.5 Eli Lilly and Company
13.6 Merck KGaA
13.7 Teva Pharmaceutical Industries Ltd.
13.8 Sanofi
13.9 Bristol-Myers Squibb
13.10 Boehringer Ingelheim
List of Figures
  • Global Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
  • Percentage of API manufacturing facilities for all drugs (August 2019)
  • World’s leading causes of death (in millions), 2019
  • World Population 65 Years & Above (% of Total), 2015-2019
  • Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Estimated number of new cases in 2020, worldwide, both sexes, all ages
  • Global Active Pharmaceutical Ingredient Market-By Application Market Share, 2020 & 2026
  • Global Active Pharmaceutical Ingredient Market- By Oncology, By Value (USD Billion), 2016-2026
  • Global Active Pharmaceutical Ingredient Market- By Cardiology, By Value (USD Billion), 2016-2026
  • Global Active Pharmaceutical Ingredient Market- By Diabetes, By Value (USD Billion), 2016-2026
  • Global Active Pharmaceutical Ingredient Market- By Neurology, By Value (USD Billion), 2016-2026
  • Global Active Pharmaceutical Ingredient Market- By Others, By Value (USD Billion), 2016-2026
  • Global Active Pharmaceutical Ingredient Market- By Drug Type Market Share, 2020 & 2026
  • Global Active Pharmaceutical Ingredient Market- By Generic API, By Value (USD Billion), 2016-2026
  • Global Active Pharmaceutical Ingredient Market- By Innovative API, By Value (USD Billion), 2016-2026
  • Global Active Pharmaceutical Ingredient Market- By Synthesis Market Share, 2020 & 2026
  • Global Active Pharmaceutical Ingredient Market- By Synthetic, By Value (USD Billion), 2016-2026
  • Global Active Pharmaceutical Ingredient Market- By Biotech, By Value (USD Billion), 2016-2026
  • Global Active Pharmaceutical Ingredient Market- By Region Market Share, 2020 & 2026
  • North America Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
  • North America Prevalence of Neurological Disorders, 2015-2019 (In Millions)
  • North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • North America Urban population, 2015-2018 (In %)
  • North America Active Pharmaceutical Ingredient players market share (%), 2020
  • North America Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
  • North America Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
  • North America Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
  • Market Opportunity Chart of North America Active Pharmaceutical Ingredient Market- By Country, By Value (Year 2016-2026)
  • North America Active Pharmaceutical Ingredient Market- By Country Market Share, 2020 & 2026
  • United States Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
  • United State year-on-year growth of Active Pharmaceutical Ingredient (in %), (2017-2026)
  • United State population aged 65 and above, (in % of total population), 2016-2020
  • United State health expenditure (% of GDP), 2013-2018
  • United State Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
  • United State Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
  • United State Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
  • Canada Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
  • Canada population aged 65 and above (% of total population), 2016-2020
  • Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Canada Urban population, 2015-2019 (In %)
  • Canada Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
  • Canada Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
  • Canada Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
  • Europe Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
  • Europe current health expenditure (% of GDP), (2014-2018)
  • Europe population aged 65 and above (% of total population), 2020
  • Europe percentage of dying between age 30 to 70 from any cardiovascular disease, cancer, diabetes and chronic respiratory disease, 2019
  • Europe Active Pharmaceutical Ingredient players market share (%), 2020
  • Europe Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
  • Europe Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
  • Europe Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
  • Market Opportunity Chart of Europe Active Pharmaceutical Ingredient Market- By Country, By Value (Year 2016-2026)
  • Europe Active Pharmaceutical Ingredient Market- By Country Market Share, 2020 & 2026
  • Germany Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
  • Germany current health expenditure (% of GDP), (2014-2018)
  • Germany population aged 65 and above (% of total population), 2016-2020
  • Germany urban population (% of total population), 2016-2019
  • Germany Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
  • Germany Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
  • Germany Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
  • United Kingdom Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
  • United Kingdom current health expenditure (% of GDP), (2014-2018)
  • United Kingdom population aged 65 and above (% of total population), 2016-2020
  • United Kingdom urban population (in millions), 2016-2020
  • United Kingdom Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
  • United Kingdom Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
  • United Kingdom Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
  • France Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
  • France current health expenditure (% of GDP), (2014-2018)
  • France urban population (% of total population), 2016-2020
  • France population aged 65 and above (% of total population), 2016-2020
  • France Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
  • France Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
  • France Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
  • Spain Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
  • Spain current health expenditure (% of GDP), (2014-2018)
  • Spain population aged 65 and above (% of total population), 2016-2020
  • Spain urban population (% of total population), 2016-2020
  • Spain Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
  • Spain Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
  • Spain Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
  • Italy Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
  • Italy current health expenditure (% of GDP), (2014-2018)
  • Italy population aged 65 and above (% of total population), 2016-2020
  • Italy urban population (% of total population), 2016-2020
  • Italy Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
  • Italy Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
  • Italy Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
  • Asia Pacific Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
  • Asia Pacific antimicrobial use (daily defined doses in millions), 2020
  • Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Asia Pacific population aged 65 years and above (% of total population), 2016-2020
  • Asia Pacific Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
  • Asia Pacific Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
  • Asia Pacific Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
  • Market Opportunity Chart of APAC Active Pharmaceutical Ingredient Market- By Country, By Value (Year-2026)
  • APAC Active Pharmaceutical Ingredient Market- By Country Market Share, 2020 & 2026
  • China Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
  • China total population in billions, 2016-2020
  • China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • China export destinations of Active Pharmaceutical Ingredient, 2019
  • China Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
  • China Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
  • China Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
  • Japan Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
  • Japan population above 65 years (% of total population), 2016-2020
  • Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
  • Japan urban population (in millions), 2016-2020
  • Japan Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
  • Japan Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
  • Japan Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Billion), 2016-2026
  • India Active Pharmaceutical Ingredient Market Size, By Value, 2016-2026 (USD Billion)
  • India Current Healthcare Expenditure (% of GDP), 2015-2018
  • India population (in billions), 2016-2020
  • India urban population (% of total population), 2015-2019
  • India Active Pharmaceutical Ingredient Market- By Application, By Value (USD Billion), 2016-2026
  • India Active Pharmaceutical Ingredient Market- Drug Type, By Value (USD Billion), 2016-2026
  • India Active Pharmaceutical Ingredient Market- By Synthesis, By Value (USD Million), 2016-2026
  • Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market- By Application (Year-2016-2026)
  • Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market- By Drug Type (Year 2016-2026)
  • Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market- By Synthesis (Year 2016-2026)
  • Market Attractiveness Chart of Global Active Pharmaceutical Ingredient Market- By Region (Year 2016-2026)
  • Global Active Pharmaceutical Ingredient players market share (%), 2020
  • Pfizer Inc., Annual Sales Revenue (USD Million), 2016-2020
  • Pfizer Inc., Annual Net Income/Loss (USD Million), 2016-2020
  • Pfizer Inc., sales Revenue, By Geographical Segment (%), FY2020
  • GlaxoSmithKline Annual Sales Revenue (USD Million), 2016-2020
  • GlaxoSmithKline Gross Profit (USD Million), 2016-2020
  • GlaxoSmithKline Sales Revenue Split, By Business Segment (%), FY2020
  • GlaxoSmithKline Sales Revenue Split, By Geography Segment (%), FY2020
  • AbbVie Inc. Annual Sales Revenue (USD Million), 2016-2020
  • AbbVie Inc. Net Income (USD Million), 2016-2020
  • AbbVie Inc. Sales Revenue Split, By Business Segment (%), FY2020
  • AbbVie Inc. Sales Revenue Split, By Geography Segment (%), FY2020
  • Novartis Annual Sales Revenue (USD Million), 2016-2020
  • Novartis Annual Net Income/Loss (USD Million), 2016-2020
  • Novartis Sales Revenue Split, By Business Segment (USD Million), FY2020
  • Novartis Sales Revenue Split, By Geography Segment (%), FY2020
  • Eli Lilly and Company Annual Sales Revenue (USD Million), 2016-2020
  • Eli Lilly and Company Annual Net Income (USD Million), 2016-2020
  • Eli Lilly and Company Sales Revenue Split, By Business Segment (USD Million), FY2020
  • Eli Lilly and Company Sales Revenue Split, By Geography Segment (%), FY2020
  • Merck KGaA Sales Revenues, 2016-2020 (USD Million)
  • Merck KGaA Gross Profit, 2016-2020 (USD Million)
  • Merck KGaA Sales Revenue Split, By Business Segment (%), FY2020
  • Merck KGaA Sales Revenue Split, By Geography Segment (%), FY2020
  • Teva Pharmaceutical Industries Ltd. Sales Revenues, 2016-2020 (USD Million)
  • Teva Pharmaceutical Industries Ltd. Net Income, 2016-2020 (USD Million)
  • Teva Pharmaceutical Industries Ltd. sales Revenues, By Business Segment (%) in North America, FY2020
  • Teva Pharmaceutical Industries Ltd. sales Revenue, By Geographical Segment (%), FY2020
  • Sanofi Sales Revenues, 2016-2020 (USD Million)
  • Sanofi Gross Profit, 2016-2020 (USD Million)
  • Sanofi Sales Revenue Split, By Business Segment (%), FY2020
  • Sanofi Sales Revenue Split, By Geography Segment (%), FY2020
  • Bristol-Myers Squibb Sales Revenues, 2016-2020 (USD Million)
  • Bristol-Myers Squibb Net Income, 2016-2020 (USD Million)
  • Bristol-Myers Squibb Sales Revenue Split, By Business Segment (%), FY2020
  • Bristol-Myers Squibb Sales Revenue Split, By Geography Segment (%), FY2020
  • Boehringer Ingelheim Revenues, 2016-2020 (USD Million)
  • Boehringer Ingelheim Net Income/Loss, 2016-2020 (USD Million)
  • Boehringer Ingelheim Sales Revenue Split, By Business Segment (%), FY2020
  • Boehringer Ingelheim Sales Revenue Split, By Geography Segment (%), FY2020
Note: Product cover images may vary from those shown

Loading
LOADING...